Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial
| Image |  |
|---|---|
| Description | journal article from 'The Lancet Oncology' published in 2021 |
| Author/s |
author: Celestia Higano Fred Saad |
| Publication date | September 2021 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work |
https://linkinghub.elsevier.com/retrieve/pii/S1470204521003764 |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |